These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19524030)

  • 1. Dose tolerability of chronically inhaled voriconazole solution in rodents.
    Tolman JA; Nelson NA; Bosselmann S; Peters JI; Coalson JJ; Wiederhold NP; Williams RO
    Int J Pharm; 2009 Sep; 379(1):25-31. PubMed ID: 19524030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
    Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC
    Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution.
    Tolman JA; Nelson NA; Son YJ; Bosselmann S; Wiederhold NP; Peters JI; McConville JT; Williams RO
    Eur J Pharm Biopharm; 2009 May; 72(1):199-205. PubMed ID: 19348016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
    Howard A; Hoffman J; Sheth A
    Ann Pharmacother; 2008 Dec; 42(12):1859-64. PubMed ID: 19017830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
    Lazarus HM; Blumer JL; Yanovich S; Schlamm H; Romero A
    J Clin Pharmacol; 2002 Apr; 42(4):395-402. PubMed ID: 11936564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh).
    Flammer K; Nettifee Osborne JA; Webb DJ; Foster LE; Dillard SL; Davis JL
    Am J Vet Res; 2008 Jan; 69(1):114-21. PubMed ID: 18167096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses.
    Colitz CM; Latimer FG; Cheng H; Chan KK; Reed SM; Pennick GJ
    Am J Vet Res; 2007 Oct; 68(10):1115-21. PubMed ID: 17916020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in Hispaniolan Amazon parrots (Amazona ventralis).
    Sanchez-Migallon Guzman D; Flammer K; Papich MG; Grooters AM; Shaw S; Applegate J; Tully TN
    Am J Vet Res; 2010 Apr; 71(4):460-7. PubMed ID: 20367055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice.
    Beinborn NA; Du J; Wiederhold NP; Smyth HD; Williams RO
    Eur J Pharm Biopharm; 2012 Aug; 81(3):600-8. PubMed ID: 22569473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of voriconazole in seven body fluids of adult horses after repeated oral dosing.
    Passler NH; Chan HM; Stewart AJ; Duran SH; Welles EG; Lin HC; Ravis WR
    J Vet Pharmacol Ther; 2010 Feb; 33(1):35-41. PubMed ID: 20444023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.
    Gao H; Pennesi M; Shah K; Qiao X; Hariprasad SM; Mieler WF; Wu SM; Holz ER
    Trans Am Ophthalmol Soc; 2003; 101():183-9; discussion 189. PubMed ID: 14971576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
    Kirkpatrick WR; Najvar LK; Vallor AC; Wiederhold NP; Bocanegra R; Pfeiffer J; Perkins K; Kugler AR; Sweeney TD; Patterson TF
    J Antimicrob Chemother; 2012 Apr; 67(4):970-6. PubMed ID: 22240402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of voriconazole after oral and intravenous administration to horses.
    Davis JL; Salmon JH; Papich MG
    Am J Vet Res; 2006 Jun; 67(6):1070-5. PubMed ID: 16740104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of voriconazole after single dose intravenous and oral administration to alpacas.
    Chan HM; Duran SH; Walz PH; Ravis WR
    J Vet Pharmacol Ther; 2009 Jun; 32(3):235-40. PubMed ID: 19646087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application.
    Wei LC; Tsai TC; Tsai HY; Wang CY; Shen YC
    Curr Eye Res; 2010 Jul; 35(7):573-9. PubMed ID: 20597643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    Soler-Palacín P; Frick MA; Martín-Nalda A; Lanaspa M; Pou L; Roselló E; de Heredia CD; Figueras C
    J Antimicrob Chemother; 2012 Mar; 67(3):700-6. PubMed ID: 22190607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study.
    Myrianthefs P; Markantonis SL; Evaggelopoulou P; Despotelis S; Evodia E; Panidis D; Baltopoulos G
    Int J Antimicrob Agents; 2010 May; 35(5):468-72. PubMed ID: 20188523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients.
    Pieper S; Kolve H; Gumbinger HG; Goletz G; Würthwein G; Groll AH
    J Antimicrob Chemother; 2012 Nov; 67(11):2717-24. PubMed ID: 22796890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.
    Dodds Ashley ES; Zaas AK; Fang AF; Damle B; Perfect JR
    Antimicrob Agents Chemother; 2007 Mar; 51(3):877-80. PubMed ID: 17145785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.